BRPI0411749A - método para a inibição do crescimento de bactérias resistentes a antibióticos pelo uso de pentano-1,5-diol - Google Patents

método para a inibição do crescimento de bactérias resistentes a antibióticos pelo uso de pentano-1,5-diol

Info

Publication number
BRPI0411749A
BRPI0411749A BRPI0411749A BRPI0411749A BR PI0411749 A BRPI0411749 A BR PI0411749A BR PI0411749 A BRPI0411749 A BR PI0411749A BR PI0411749 A BRPI0411749 A BR PI0411749A
Authority
BR
Brazil
Prior art keywords
diol
composition
resistant bacteria
pentane
growth
Prior art date
Application number
Other languages
English (en)
Inventor
Jan Faergemann
Thomas Hedner
Original Assignee
Ambria Dermatology Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambria Dermatology Ab filed Critical Ambria Dermatology Ab
Publication of BRPI0411749A publication Critical patent/BRPI0411749A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"MéTODO PARA A INIBIçãO DO CRESCIMENTO DE BACTéRIAS RESISTENTES A ANTIBIóTICOS PELO USO DE PENTANO-1,5-DIOL". Um método para a inibição do crescimento de bactérias multi-resistentes compreende a administração tópica de uma composição farmacêutica que compreende 15% em peso ou mais de pentano-1,5-diol e um veículo farmaceuticamente aceitável. Também é revelado um método de preparação de um medicamento correspondente. Um método de desinfecção de uma superfície contaminada com bactérias multi-resistentes compreende o fornecimento de uma composição desinfetante que compreende 15% ou mais em peso de pentano-1,5-diol e um veículo adequado, aplicação da referida composição à superfície; opcionalmente, a manutenção da composição em contato com a superfície por um período de tempo de 5 min a 24 horas em temperatura ambiente e o enxágüe da referida superfície com água ou uma composição detergente aquosa. Também é revelado o uso da composição bacteriostática correspondente.
BRPI0411749 2003-06-26 2004-06-23 método para a inibição do crescimento de bactérias resistentes a antibióticos pelo uso de pentano-1,5-diol BRPI0411749A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0301862A SE0301862D0 (sv) 2003-06-26 2003-06-26 Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
PCT/SE2004/001001 WO2004112765A1 (en) 2003-06-26 2004-06-23 Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol

Publications (1)

Publication Number Publication Date
BRPI0411749A true BRPI0411749A (pt) 2006-08-08

Family

ID=27656597

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411749 BRPI0411749A (pt) 2003-06-26 2004-06-23 método para a inibição do crescimento de bactérias resistentes a antibióticos pelo uso de pentano-1,5-diol

Country Status (16)

Country Link
US (1) US7973080B2 (pt)
EP (1) EP1635802B1 (pt)
JP (1) JP4824553B2 (pt)
KR (1) KR20060103817A (pt)
CN (1) CN1812775B (pt)
AT (1) ATE403421T1 (pt)
AU (1) AU2004249102A1 (pt)
BR (1) BRPI0411749A (pt)
CA (1) CA2529287A1 (pt)
DE (1) DE602004015597D1 (pt)
DK (1) DK1635802T3 (pt)
ES (1) ES2313038T3 (pt)
PL (1) PL1635802T3 (pt)
RU (1) RU2355392C9 (pt)
SE (1) SE0301862D0 (pt)
WO (1) WO2004112765A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006057616A1 (en) 2004-11-29 2006-06-01 Ambria Dermatology Ab A composition comprising at least 3 different diols
JP2009517152A (ja) * 2005-11-29 2009-04-30 アンブリア ダーマトロジー アーベー 消臭剤としてのペンタン−１，５−ジオールを含む組成の使用
SE533425C2 (sv) * 2008-07-07 2010-09-21 Ambria Dermatology Ab Antimikrobiell sammansättning
FR2940281B1 (fr) 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
CN103816165B (zh) * 2014-03-11 2019-03-01 北京德默高科医药技术有限公司 一种治疗痤疮的组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136089A (en) * 1975-02-22 1979-01-23 Bayer Aktiengesellschaft Molded articles of crystalline poly (ethylene/alkylene) terephthalates which crystallize rapidly
DE3727128A1 (de) * 1987-08-14 1989-02-23 Bayer Ag Verfahren zur herstellung von in der waerme haertbaren einkomponenten-polyurethan-polyharnstoff-systemen
EP0381617B1 (en) * 1989-01-31 1996-05-15 Ciba-Geigy Ag Disinfecting and cleaning composition for contact lenses
US5369129A (en) * 1989-06-13 1994-11-29 Hydro Pharma Ab Preparation of topical treatment of infections caused by virus, bacteria and fungi
SE464060B (sv) 1989-06-13 1991-03-04 Gunnar Swanbeck Anvaendning av pentandiol eller hexandiol foer framstaellning av ett medel foer behandling av infektioner orsakade av herpesvirus
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
US5370876A (en) * 1993-01-08 1994-12-06 Microbarriers Antimicrobial protective skin composition and method for protecting skin from body fluids
US5879690A (en) * 1995-09-07 1999-03-09 Perricone; Nicholas V. Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
BR9709920A (pt) * 1996-06-20 2000-01-11 Lavipharm Sa Dispositivo para tratamento tópico da acne e seu método de manufatura
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
ES2240868T3 (es) * 1997-04-04 2005-10-16 Mitsubishi Pharma Corporation Compuesto de 2-aminopropano -1,3-diol, su uso farmaceutico e intermedios en su sintesis.
DE19741554B4 (de) * 1997-09-20 2005-04-14 Basf Coatings Ag Härtbare Beschichtungszusammensetzung sowie Verfahren zur Herstellung eines schützenden Überzugs
US6548074B1 (en) 1999-07-22 2003-04-15 Elizabeth Arden Co., Division Of Conopco, Inc. Silicone elastomer emulsions stabilized with pentylene glycol
RU2160578C1 (ru) * 2000-04-10 2000-12-20 Открытое акционерное общество "Новосибхимфарм" Бактерицидный пластырь
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
RU2205033C2 (ru) * 2001-04-13 2003-05-27 Болдырев Сергей Николаевич Лечебный материал пролонгированного действия
US20020192273A1 (en) * 2001-06-15 2002-12-19 Teri Buseman Therapeutic patch useful for the treatment of hemorrhoids

Also Published As

Publication number Publication date
KR20060103817A (ko) 2006-10-04
JP2007521265A (ja) 2007-08-02
JP4824553B2 (ja) 2011-11-30
CA2529287A1 (en) 2004-12-29
ES2313038T3 (es) 2009-03-01
WO2004112765A1 (en) 2004-12-29
CN1812775B (zh) 2011-07-27
US7973080B2 (en) 2011-07-05
US20070020322A1 (en) 2007-01-25
DE602004015597D1 (de) 2008-09-18
SE0301862D0 (sv) 2003-06-26
DK1635802T3 (da) 2008-12-08
AU2004249102A1 (en) 2004-12-29
CN1812775A (zh) 2006-08-02
RU2355392C9 (ru) 2009-07-27
PL1635802T3 (pl) 2009-01-30
EP1635802B1 (en) 2008-08-06
ATE403421T1 (de) 2008-08-15
RU2355392C2 (ru) 2009-05-20
RU2005140049A (ru) 2006-07-27
EP1635802A1 (en) 2006-03-22

Similar Documents

Publication Publication Date Title
ECSP088869A (es) Derivados de 2-pirazinona para el tratamiento de enfermedades o condiciones en donde resulta beneficiosa la inhibición de la actividad de la elastasa neutrofílica
NO20051986L (no) Sammenhengende frigivelsesavlevering av amfetaminsalter.
CR10838A (es) Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
UY27300A1 (es) Nuevos derivados de quinolina
ECSP034914A (es) "azaindoles"
ECSP055531A (es) "nuevos derivados de glicósido de tiofeno, metodos para la preparacion de los mismos, medicamentos que comprenden dichos compuestos, y su uso"
UY28510A1 (es) Compuestos quimicos
UY27446A1 (es) Nuevos compuestos
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
BR0213612A (pt) Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição
UA94901C2 (ru) Антибактериальные производные пиперидина
UY28040A1 (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos.
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
NO20065904L (no) Terapeutiske forbindelser
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
HN1999000183A (es) Preparado farmaceuticos de moxifloxacina
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
AR044200A1 (es) Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo
CO5611124A2 (es) Derivados de benzofurano substituidos utiles en el tratamiento de desordenes hiper-proliferativos
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
BRPI0408240A (pt) composto, utilização de um composto e composição farmacêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.